1 / 15

Dialysis vs Transplant: the Australia & New Zealand experience

Dialysis vs Transplant: the Australia & New Zealand experience. Stephen McDonald ANZDATA Registry Adelaide, South Australia. Background. Reports from USRDS have shown a survival advantage for renal transplant recipients (RTR) both overall and in higher risk group (blacks)

mpressley
Download Presentation

Dialysis vs Transplant: the Australia & New Zealand experience

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia

  2. Background • Reports from USRDS have shown a survival advantage for renal transplant recipients (RTR) both overall and in higher risk group (blacks) • Those on waiting list have 50% mortality of others (<70 years) • Increased risk of mortality higher in initial phase (2.8), equalise at 3 months and equal cumulative survival at 8 months (long term HR 0.32) • Australia data have shown a similar survival advantage for older cadaveric RTR in one centre Johnson et al, 2000 Dialysis Transplant mortality, Darwin 2001

  3. Methods • Inclusion criteria • “likelihood of transplantation” recorded from 1 Nov 1981 • All ESRD entrants where first treatment recorded after this date • Likelihood of transplantation = 10 “on waiting list” on at least one occasion • or 92 “Excellent match desired” • Date of listing not available • Midpoint of 1st survey period when “On list” recorded used as surrogate for time of listing (unless transplanted earlier) • Outcome=Death • Deaths < 60 days post transplant failure attributed to transplantation • Patients censored at return to dialysis Dialysis Transplant mortality, Darwin 2001

  4. Methods • Comparison of dialysis and transplant group survival • Using time of transplant as time 0 • Cox survival analysis with time-varying covariates • Looks at survival difference, allowing for time post ESRD entry by “crossing over” at time of grafting • Separate terms for survival early and late stages post transplantation • “Intent-to-treat” analysis • Not censored if withdrawn from list Dialysis Transplant mortality, Darwin 2001

  5. Cohort 1 • All people “waitlisted” post 1981 • No account taken of co-morbidity • These records only available post 1991 • All ages 15-65, first graft, multiple & OS grafts excluded • n=10642 (of 24402 entries to ESRD) • Cohort 2-all waitlisted people post 1991 • 2 groups compared • “low risk” – first grafts, no co-morbidities, age 15-50 • N=2560 • “marginal” – diabetes (any type), age 50-65 • N=2732 Dialysis Transplant mortality, Darwin 2001

  6. Kaplan-Meier survival estimates, by waitlist 1.00 Active list at least once 0.75 0.50 Never active 0.25 0.00 0 5 10 Analysis time (years) Waiting list and mortality Kaplan Meier curve of survival on dialysis (censored at transplantation) of patients <40 y.o. at ESRD entry 1981-2000, grouped by active transplant status at least once Dialysis Transplant mortality, Darwin 2001

  7. Cohort characteristics • 3581/10642 (34%) people did not receive a graft at some stage • 1167 (20%) received LD, 5714 CD • Those grafted more likely to be • Male (67 vs 63%, p<0.0001) • Younger – CD recipients 4.5 years younger on average than non-grafted group Dialysis Transplant mortality, Darwin 2001

  8. Outcomes • Dialysis group • 6881 transplanted • 1654 deaths • 1921 alive at censor date • Transplant group • Median duration of dialysis pre transplant • 18 months for CD, 7 months for LD • 924 deaths with functioning graft, + 177 within “60 day rule” • 1370 fails -> dialysis • 4026 alive at censor date • 77 (1.1%) lost to follow-up Dialysis Transplant mortality, Darwin 2001

  9. Survival rates YearsDialysisTransplant 3 months 0.99 0.97 12 months 0.97 0.95 2 0.91 0.93 3 0.83 0.91 5 0.66 0.87 10 0.33 0.74 Actuarial survival on dialysis post Tx listing and post-transplant, 1981-2000. Crude comparisons. Dialysis Transplant mortality, Darwin 2001

  10. Time varying covariates Cox analysis of mortality post transplantation (CD recipients only). Transplantation inserted as 4 level time-varying covariate. Referent HR=dialysis group. Gender not significant predictor. Dialysis Transplant mortality, Darwin 2001

  11. Cohort 2 - TVC • Survival advantage similar in “good” and “ marginal” recipients • Age adjusted figures MonthsHR (non-marginal) HR (marginal) 0-3 2.00 [1.17-3.44], p=.01 1.99 [1.43-2.76] p<0.001 3-6 .40 [.13-1.27], p=.12 .79 [.48-1.30], p=.36 6-12 .43 [.20-.92],p=.03 .27 [.15-.48], p<0.001 12- .18 [.12-.28], p<0.001 .16 [.12-.21], p<0.001 Dialysis Transplant mortality, Darwin 2001

  12. Absolute Rates Marginal 20 Non-marginal 15 Mortality rate / 100 / yr 10 5 0 Dialysis 0-3 3-6 6-12 >12 months Post transplant status Dialysis Transplant mortality, Darwin 2001

  13. Discussion • After initial higher risk of mortality, there is a survival advantage for transplant recipients from 3 months post surgery • Cumulative survival advantage begins from 2 years post transplantation • Due to very high early survival rates in dialysis group • The survival advantage applies comparably across the cohorts examined • Detailed examination of subgroups not presented • Stratification used to approach co-morbids Dialysis Transplant mortality, Darwin 2001

  14. Discussion • Methodologic issues • time varying covariates • accounts for time on waiting list • “cross over” at Tx date • Should you adjust for age? • What should be done with those who drop off the list? • How far post Tx failure should you count deaths? • 60 days, 3 months, 12 months? Further work • Prospective follow-up of cohorts from time of listing • More detailed acquisition of co-morbid information Dialysis Transplant mortality, Darwin 2001

  15. Acknowledgements • ANZDATA Registry staff • Lee Excell, Brian Livingston, Liz Steinmetz Don’t forget our website: www.anzdata.org.au Dialysis Transplant mortality, Darwin 2001

More Related